Methscopolamine Pregnancy and Breastfeeding Warnings
Brand names: Pamine, Pamine Forte
Medically reviewed by Drugs.com. Last updated on Jul 24, 2023.
Methscopolamine Pregnancy Warnings
Use is not recommended unless clearly needed.
US FDA pregnancy category: C
Animal studies have not been conducted. There are no controlled data in human pregnancy. It is unknown if this drug can cause fetal harm or affect reproduction capacity.
US FDA pregnancy category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.
Methscopolamine Breastfeeding Warnings
Caution is recommended.
Excreted into human milk: Unknown
Excreted into animal milk: Data not available
Comments:
-Anticholinergic drugs may suppress lactation.
See also
References for pregnancy information
- Product Information. Pamine Forte (methscopolamine). PharmaDerm. 2006.
- Product Information. Methscopolamine Bromide (methscopolamine). Boca Pharmacal Inc. 2017.
References for breastfeeding information
- Product Information. Pamine Forte (methscopolamine). PharmaDerm. 2006.
- Product Information. Methscopolamine Bromide (methscopolamine). Boca Pharmacal Inc. 2017.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.